September 12 2023
MY01, Inc. sets the gold standard for aiding in the diagnosis of compartment syndrome by surpassing a 1000 case milestone. This highlights the Continuous Compartmental Pressure Monitor’s vital role in enhancing clinical assessments and augmenting healthcare collaborations.
April 11 2023
Communiqué de presse
MY01, Inc. has raised a $12.5 million USD Series A funding round. The round is led by Investissement Quebec, with participation from Desjardins Capital and Fondaction. The funding will be used to expand commercialization activities in the United States. View our video announcement
Nov 22 2022
Communiqué de presse
Jay was recently the Global Franchise Leader at Integra Life Sciences and had responsibility for the $300+ million dollar global wound reconstruction business. She joined Integra as part of the acquisition of ACell Inc where she was the General Manager, Global Surgical and Cardiac. Prior to this role at ACell, Jay had responsibility as the Sr. Director of Marketing focused on downstream marketing activities, communications, market access, and reimbursement. Previously, Jay held marketing leadership positions at Becton Dickinson, Carefusion, Olympus, and B. Braun. Jay has a B.S. in Mechanical Engineering from Case Western Reserve University and an MBA from Lehigh University College of Business.
Nov 7 2022
Communiqué de presse
In a poster titled “An Early Cost-Effectiveness Analysis of a New Continuous Compartment Pressure Monitoring Device in Tibial Fracture Patients Who Are at Risk of Developing Acute Compartment Syndrome (ACS),” the York Health Economic Consortium concludes that using the MY01 device may reduce overall costs for tibial fracture patients at risk for ACS. The model demonstrated a per patient savings of £367 in the 60 days after injury in addition to a 1.2 day reduction in the length of stay.
Oct 15 2022
Communiqué de presse
The symposium, titled “New Tools and Approaches in the Management of Compartment Syndrome,” discussed the current limitations of ACS management and diagnosis, and the potential use of the MY01 device as an accurate aid to diagnosis.
Oct 14 2022
Communiqué de presse
Data from a paper titled, “Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients with an Upper or Lower Extremity Fracture at Risk for Acute Compartment Syndrome” was given in a podium presentation by Dr. Ross Leighton, professor of surgery at Dalhousie University. Results showed that as a complement to clinical signs, the use of the MY01 Continuous Compartmental Pressure Monitor resulted in all cases of ACS being accurately diagnosed, with no missed cases and no false positives.
Oct 13 2022
Communiqué de presse
MY01 Announces Presentations of Clinical Trial Data at Orthopaedic Trauma Association Annual Meeting
Interim data used in the diagnosing of Acute Compartment Syndrome (ACS) from two ongoing, prospective, multi-center studies will be presented at the Orthopaedic Trauma Association (OTA) Annual Meeting in Tampa, Florida. The results of these independent studies will be presented during three different sessions of the meeting.
Oct 11 2022
Charles Moon, MD, Director of the Orthopaedic Trauma Program at Cedars-Sinai, speaks during a session focusing on recent developments concerning acute compartment syndrome. He will introduce a new way of providing continuous compartmental pressure that may aid in the diagnosis of acute compartment syndrome.
Sept 9 2022
Communiqué de presse
The presentation, entitled “Clinical Trial on Continuous Compartmental Pressure Monitoring for Acute Compartment Syndrome” demonstrated that the MY01 continuous compartmental pressure monitor is an accurate aid to diagnosing acute compartment syndrome (ACS). The use of continuous pressure monitoring paired with clinical signs yielded no missed cases of ACS and no false positives. In addition, more than 90% of participating clinicians indicated that they would recommend the MY01 device for use in all long bone fractures.
Jun 13 2022
Communiqué de presse
MY01 Announces Presentation of Initial Clinical Trial Data at Canadian Orthopaedic Association Annual Meeting
The presentation, entitled “Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients with an Upper or Lower Extremity Fracture at Risk for Acute Compartment Syndrome” reported that 88% of surgeons rated the device very good or excellent with regards to their confidence in the function of the device and its ability to monitor pressure continuously. 90% of users rated the device as very easy to deploy.
Oct 27 2021
MY01 Inc. receives their first-ever “Breakthrough Device” designation by the FDA in October, joining a select list of Orthopaedic companies to receive this designation since the program began in 2016.
Oct 25 2021
MY01 attended the American College of Emergency Physicians (ACEP) meeting in Boston, MA. We were excited by the reception and interest Emergency Physicians shared for our device. They could see how it could help them make better decisions under pressure.
September 3rd 2021
Delayed diagnosis and treatment (late fasciotomy) can have catastrophic consequences for the patient with 5.7% of all cases leading to amputation(1). Amputation carries a lifetime cost of 600,000$ and significant legal liability risk(2).
August 4th 2021
After months of hard work from our team, we are glad to announce that 300 surgeons have now been fully trained to use our continuous compartment pressure monitor across North America and Europe.
We look forward to expanding our reach within hospitals and would welcome the opportunity to book discovery discussions.
July 28th 2021
“Cold Steel” Podcast
Our CMO, Dr. Ed Harvey, has made a second appearance on the Canadian Journal of Surgery podcast “Cold Steel” hosted by Dr. Chad Ball. In this episode, they discussed innovation by dissecting the meaning of this frequently used keyword, as well as touching on the different aspects needed for one to achieve it.
Both podcasts linked below:
July 21st 2021
EFORT 2020 abstract
As the year 2020 was filled with missed or virtual events, we will be posting some of the great research MY01 has been a part of. To kickstart this recap, we presented multiple abstracts at the EFORT virtual congress in 2020 with one of our best one being the “Does the Deep Posterior Compartment Exist? An Updated Lower Leg ACS”.
July 14th 2021
The Canadian Orthopaedic Association (COA) held a great virtual event for their annual meeting last month. Our CEO Charles Allan and our CMO Dr. Ed Harvey hosted a talk on start-ups and funding where all the doctors present will be or are currently using our device.
During their presentations, our CEO, Charles Allan and our CMO Dr. Ed Harvey covered a slew of topics surrounding start-ups and their funding. The highlights of the event where:
-The challenges of innovation whilst being a surgeon : Idea needs to have marketable potential
-The importance of your team : surrounding yourself with the right people can make or break your venture
-Challenges and funding opportunities in the early stages of a start-up
July 7th 2021
JBJS “Orthojoe” Podcast
The JBJS “Orthojoe” podcast episode 12 about innovation that featured Dr. Ed Harvey, our CMO, now has the video interview available. Dr. Marc Swiontkowski and Dr. Mohit Bhandari asked some compelling questions about innovation from a surgeon’s point-of-view and the road taken to achieve success.
Click here to check it out.
June 9th 2021
The annual COA meeting will be held next week, from June 15th to June 19th. We will be presenting at the online conference as our CEO Charles Allan and our CMO Dr. Ed Harvey will be discussing start-ups and how to fund your side gig.
June 7th 2021
Our CEO, Charles Allan, recently sat down with Conn Hastings from Medgadget to discuss the prevalence of compartment syndrome. Charles also commented on why the MY01 Continuous Compartment Pressure Monitor is the only device on the market that practically enables precise digital pressure readouts continuously over time.
June 2nd 2021
Fraser Gurd Surgical Research Day
For this year’s Annual McGill Fraser Gurd Surgical Research Day held on the 27th of may, our CMO, Dr. Ed Harvey, gave a talk on “Wearables, Sensors, and Digital Health”. This event is the main event of Mcgill’s department of surgery that showcases resident and staff driven research.
May 26th 2021
Our CMO Dr. Ed Harvey was a guest on the JBJS podcast OrthoJoe hosted by Dr. Marc Swiontkowski and Dr. Mohit Bhandari to discuss innovation; what it really entails and the importance of building the right team if you want to succeed. The episode aired on the 24th of May and is available here.
May 19th 2021
The American Association of Orthopedic Surgeons (AAOS) recommends Continuous Pressure Monitoring as the best method for ruling out Compartment Syndrome. The MY01 Continuous Compartmental Pressure Monitor was purpose built to do just that! Only the MY01 device provides quick, reliable and continuous pressure measurements to aid in diagnosis of Compartment syndrome. Giving medical professionals a tool they can use to follow the AAOS CPG guidelines.
May 12th 2021
We are honoured to have been selected in Fast Company’s World Changing Ideas of 2021. Our mission is to empower healthcare professionals with the ability to pre-empt severe medical conditions. Improving patient outcomes drives our team towards excellence and constant innovation.
Apr 28th 2021
MY01’s Continuous Compartmental Pressure Monitor is designed to aid healthcare professionals in diagnosing Acute Compartment Syndrome. The rapidly evolving condition, if misdiagnosed, can lead to unnecessary fasciotomies, necrosis or even to potential amputations.
Apr 21st 2021
Three Devices Comparison
The Journal of Military Medicine published a paper comparing performance of the three different devices to measure pressure for diagnosis of Acute Compartment Syndrome.
The study shows that compared to the Synthes and the STIC devices, the MY01 Continuous Compartmental Pressure Monitor showed 600% more accurate results in tracking pressure changes and thus is the truest indicator of reference pressure in the ACS model.
Apr 14th 2021
Future of Healthcare Podcast
The featured guest this week on the Future of Healthcare, a podcast highlighting new trends in the healthcare industry was our Chief Medical Officer, Dr. Ed Harvey. He and Marta Bordignon discussed his experience as a co-founder of MY01, with a deeper dive into the entrepreneurial side of MY01.
Topics such as the company’s origin story to the importance of having the right team are explored throughout the podcast.
Tune in to the podcast to learn more : https://lnkd.in/dJAyeAh
Apr 7th 2021
Company Value: Mindfulness
We are mindful of our people: We make sure all our customers, patients, physicians and Hospitals are top of mind when making decisions both small and large.
At MY01, we take pride in being customer driven and aiming to provide a superior experience every step of the way. We implement our company values in everything we do so we can achieve our mission to empower healthcare professionals with the ability to pre-empt severe medical conditions thereby improving patient outcomes.
Mar 31th 2021
Company Value: Purpose
We act with purpose: We take pride in our work and stand by our decisions as a team. Every contribution, opinion and idea matters.
At MY01, we strive to foster a culture where our team members can attain their full potential and grow within our ranks. We implement our company values in everything we do so we can achieve our mission to empower healthcare professionals with the ability to pre-empt severe medical conditions thereby improving patient outcomes
Mar 24th 2021
MY01’s commitment to health and wellness starts at home! Every week on Wednesdays, some of our team members (socially distance) gather to participate in the MY01 run & walk as part of our team health challenge. This initiative helps promote an active lifestyle within our ranks while allowing for some team bonding time.
Mar 17th 2021
Acute Compartment Syndrome (ACS) is a rapidly evolving condition that requires clinical assessment and ideally Continuous Intracompartmental Pressure Continuous (ICP) monitoring as it can aid and facilitate decision making where clinical assessments alone fail to indicate the early signs of ACS.
The American Academy of Orthopaedic Surgeons (AAOS) recognizes the importance of Continuous ICP in diagnosing ACS. The MY01 device leverages MicroElectroMechanical System (MEMS) technology to continuously measure a patient’s Intracompartmental Pressure. Compared to current methods, MEMS sensing technology allows for reliable continuous ICP measurement, aiding timely detection of ACS.
Mar 8th 2021
International Women’s Day
Today, on International Women’s Day, we want to take a moment to celebrate all the Women in our network and in our wider community. Let this day serve as a call to action for accelerating gender parity and as a reminder that we must continue to promote full and equal access to participation in science for women and girls around the world. At MY01, we vouch to be an equal opportunity and affirmative action employer and we are committed to advancing gender equality in the workplace.
Mar 3rd 2021
An unfortunate car crash has led to Tiger Woods, one of the best golf players in the world, to be hospitalized because of a severely broken leg. He developed compartment syndrome and had to undergo a fasciotomy to release the pressure in his muscle. “If that pressure doesn’t get released quickly – and by quickly, I mean within an hour or so – it can cause permanent damage, it can even lead to amputation.” per Dr. Torres. The MY01 device is purpose built to aid healthcare professionals in the diagnosis of acute compartment syndrome (ACS) to ensure that the syndrome is caught in a timely manner.
Feb 24th 2021
Teams Technical Expertise
At MY01, we are dedicated to providing healthcare professionals with the ability to pre-empt severe medical conditions. Our team has been continuously growing over the last few years, and we now count 50 employees across our different subsidiaries, from 20 countries (and totalling 80 graduate and postgraduate degrees).The technical expertise and the diverse nature of our team has allowed for an influx of knowledge and creativity that has led to us becoming leaders in the development of MEMS sensor technology.
Feb 17th 2021
Pushing the Envelope
On Friday the 12th, MY01 participated in the 11th annual Orthopaedic Trauma & Fracture Care class. Dr. Harvey’s presentation on the value of our device in aiding in the diagnosis of Acute Compartment Syndrome was followed up by Dr. Leighton’s presentation (one of our lead champion surgeons) on his latest research which utilizes the MY01 continuous compartmental pressure monitor.
Feb 10th 2021
MY01 is thrilled to kick off our 2021 event calendar at the OBIO investment summit. Our CEO, Charles Allan, will be sharing our progress towards becoming part of the standard of care for compartment syndrome at 1 pm EST, Wednesday the 10th. The virtual event, which starts today, will allow us to share the stage with leaders from fellow Canadian Medtech companies and connect with the community.
Feb 4th 2021
We are pleased to share that our Continuous Compartmental Pressure Monitor received its CE mark and is commercially available across the European Union. Our team is extremely excited to collaborate with European healthcare practitioners and would welcome the opportunity to book discovery discussions.
This huge milestone will allow us to further our mission of empowering healthcare workers all over the world with the ability to pre-empt severe medical conditions.
Jan 13th 2021
The American Academy of Orthopaedic Surgeons (AAOS) recognizes that continuous intracompartmental pressure is an important measure to monitor when concerned with Acute Compartment Syndrome (ACS). MY01 believes that optimal management of ACS lies in a combinational approach, augmenting standard clinical practice with continuous compartmental pressure monitoring.
MY01 was purpose built, using physician feedback, to enable continuous pressure monitoring.
Jan 6th 2021
Our CEO, Charles Allan, sat down with CEOCFO magazine’s Senior Editor, Lynn Fosse, to discuss an array of topics regarding our company and device. A comprehensive dive into our mission to empower healthcare professionals and the cost benefits related to the use of MY01 are just a few of the subjects tackled during this interview.
We look forward to the upcoming year as we plan to further expand our presence in hospitals and aid in the diagnosis of ACS.
Feb 25th 2020
MY01 first in human test
When you really stand behind your product you don’t need to look too far for a volunteer to test it on. None other than our CEO Charles Allan was the volunteer for our first in-human test.
Feb 17th 2020
MD&M West 2020 Conference
George and Faisal at the Medical Design & Manufacturing (MD&M) West 2020 conference getting to visit our existing suppliers. They also took the opportunity to find new suppliers and technology for the manufacturing of MY01.
Feb 6th 2020
MY01 is present at Mcgill Techfair
MY01 was born from a research project at McGill and we keep recruiting talent from our Alma Mater. For the second year in a row we had the opportunity to present our company at the McGill engineering department open house. We met several candidates for new interns.
Jan 21st 2020
EWI SOMOS 2020
MY01 was present at the Extremity War Injuries Society of Military Orthopedic Surgeons (EWI SOMOS) conference in Washington DC. We were selected to present two posters titled “Comparison of devices for acute compartment syndrome under real world conditions” and “Validation of a human model of compartment syndrome”